BioSpace News Archive

Nexodyn® AcidOxidizing Solution is now starting to be available in Saudi Arabia and United Arab Emirates (UAE), promoted and commercialized by the leading pharmaceutical company Cigalah Medpharm, part of Cigalah Group, following an exclusive partnership with the Swiss Pharma company APR Applied Pharma Research (“APR”).

Strategic Deal Extends and Diversifies Company’s Footprint in Life Science Research

Now Also Runs on PCs, Macs, and iPads

The National Sciences and Engineering Research Council of Canada has funded a University of Victoria project aimed at collaborating with RepliCel to optimize cell culture and manufacturing technologies

Danaher Corporation today announced results for the third quarter 2018. For the quarter ended September 28, 2018, net earnings were $663.7 million, or $0.93 per diluted share which represents a 15.0% year-over-year increase.

Viseon, Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for their Voyant System for Minimally Invasive Spine Surgery, featuring proprietary HD imaging sensor and illumination technology.

First Product MZS Sleeping Aid™ Currently Expected to Launch in the U.S. in Q4 2018

Technology Promotes High-Quality Results from Liquid Biopsy Cancer Tests

Lunch Symposium to Highlight Use of Cytal Wound Matrix and MicroMatrix in Traumatic Wounds with Exposed Avascular Structures

Synpromics is pleased to announce positive data presented today by a key partner, uniQure (NASDAQ:QURE), at the European Society of Gene and Cell Therapy conference in Lausanne, Switzerland.